0 results for 'Valeant Pharmaceuticals International Inc'
Actavis Buys Forest Labs for $25B
Mergers and acquisitions across the state, including a $25 billion buy for Actavis, and $425 million purchase for Valeant.Leading M&A Transactions-Target or Acquirer Based in N.J.-2013
Leading M&A transactions with the target or acquirer based in N.J. in 2013.Cold Remedy: Am Law 100 Firms Load Up on Pharma M&A
Pharmaceutical M&A got a late-year shot in the arm, with nearly $10 billion in deals involving major industry players like AstraZeneca and Bayer as 2013 came to a close. A bevy of Am Law 100 firms led by Covington, Kirkland, Sullivan & Cromwell, Skadden, and Weil have grabbed lead roles on the transactions.Valeant Buying Solta Medical for About $250M
Valeant Pharmaceuticals International Inc. is buying Solta Medical Inc. for about $250 million.Geithner Joins Warburg in Shift to Buyouts From Bailouts
As he starts his career on Wall Street next year, former Treasury Secretary Timothy Geithner has chosen a buyout firm, New York-based Warburg Pincus LLC.Four Am Law 100 Firms Advise on Valeant's $2.6 Billion Skin Care Deal
Canadian health care company Valeant Pharmaceuticals International will pay $2.6 billion to acquire Medicis Pharmaceutical Corporation in a deal that bolsters Valeant's position in the skin care products market. Sullivan & Cromwell, Skadden, Latham, and Weil Gotshal all landed roles on the transaction.Creating a Culture of Compliance
Brought to you by Ironclad
Download Now
A Buyer's Guide to Law Firm Software
Brought to you by PracticePanther
Download Now
A Step-by-Step Flight Plan for Legal Teams: Fire Up Your Productivity Engine and Deliver High-Impact Work Faster
Brought to you by HaystackID
Download Now
Corporate Transparency Act Resource Kit
Brought to you by Wolters Kluwer
Download Now